Lung volume reduction for emphysema

Number of report

Ask the expert

(we accept only company emails)

The report presents a summary of reimbursement situation for lung volume reduction for emphysema.

Video-assisted thoracoscopic and minimally invasive bronchoscopic lung volume reduction procedures using endobronchial valves, endobronchial coils and vapour thermal ablation is considered in the report.

The only reimbursement within public / statutory health insurance systems is considered.

The report includes essential information about reimbursement and national funding, including:

  • Brief overview of reimbursement system for medical devices
  • Procedure coding for technology
  • Diagnosis coding
  • Payment mechanism for technology
  • Reimbursement tariffs for technology
  • Restrictions in indications or scenarios for use of technology
  • Policy considerations by payers and policy-makers about technology

Reimbursement information is provided for the following geographies:

  • Austria
  • Belgium
  • Denmark
  • England (UK)
  • France
  • Germany
  • Italy
  • Netherlands
  • Norway
  • Sweden
  • Switzerland

It is also possible to add analysis in Czech Republic, Finland, Hungary, Romania, Russia and Turkey.

Manufactures for lung volume reduction for emphysema include:

  • Aeris Therapeutics (Aeris Polymeric Lung Volume Reduction (PLVR) System)
  • BTG (PneumRx)
  • Broncus (Airway Bypass)
  • Nuvaira (Nuvaira™ Lung Denervation System)
  • Olympus (Spiration Valves)
  • PulmonX (Zephyr, ChartisTM system)
  • Uptake Medical (InterVapor)

Table of content is not available at the moment.

(we accept only company emails)